BBTV

About Us

Report on Location

all episodes

2010 JP Morgan Healthcare Conference Report

  1. Who is Investing in Biotech Today? Kris Jenner
  2. Reconsidering Small and Mid Caps, IPOs, and Value Drivers. Kris Jenner
  3. Shareholder Activism in 2010, Good or Bad? Kris Jenner
  4. 2010 JP Morgan Healthcare Conference, the Insider Perspective
  5. Key Issues for Venture Capital Invetments and Fund Raising. Ansbert Gadicke
  6. Pharma Opportunities, Novel Technologies, and Diseases of the Decade. Ansbert Gadicke
  7. The Insider Perspective, with Geoff Meacham (Part 1)
  8. The Insider Perspective, with Geoff Meacham (Part 2)

Lee Buckler Reports from the 2009 Phacilitate Cell & Gene Therapy Forum

1. Lee Buckler’s Cell Therapy ‘08 Review and ‘09 Outlook
2. Harvard Steps Into the Cell Therapy Funding Gap with a Mission for Academic Research to Get to Patients
3. Roche’s Vertes on Big Pharma’s Interest in Cell Therapy

MASHUP from the 2009 Phacilitate Cell & Gene Therapy Forum

1. How Would You Define Cell Therapy?
2. Are We Going to See New Cell Therapy Products in the Next 2-3 Years?
3. How Many Cell Therapy Products Are On the Market Today?
4. What Are Some of the Exciting Things Happening in Cell Therapy?

  • Categories

    • Shows
      • Biotech in the Money
      • Wall Street on BBTV
      • Science Breakthrough
      • The Jan Buck Show
      • 60sec Pitches
      • Special Interview
      • Report on Location
      • Wall Street
    • Series
      • The Stem Cell Review
      • Alzheimer's Today
      • The MedTech Report
      • Stem Cell Review
    • Channels
      • Science
      • Finance
      • Business
    • About
      • about sub
      • about sub 2

  • Acknowlegments

    nasdaq nasdaq

  • About the Series

    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.

    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.

    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • Channels
    • Science
  • Series
    • The Stem Cell Review
  • Shows
    • Biotech in the Money
    • Report on Location
    • Science Breakthrough
    • Special Interview
    • The Jan Buck Show
    • Wall Street
    • Wall Street 2
    • Wall Street on BBTV
  • About
    • about sub
    • about sub 2